Literature DB >> 19322586

Identification and chromosomal localization of one locus of Leishmania (L.) major related with resistance to itraconazole.

L A Camizotti1, E H Yamashiro-Kanashiro, Paulo C Cotrim.   

Abstract

Ergosterol is an important compound responsible to maintain integrity and fluidity of Leishmania spp. membranes. Starting from an overexpression/selection method, our group has isolated and mapped nine different loci of Leishmania (L.) major related to resistance against two inhibitors of the ergosterol biosynthesis pathway, terbinafine (TBF) and itraconazole (ITZ). Individual functional analysis after overexpression induction of these loci in the presence of TBF and/or ITZ [or the ITZ analog ketoconazole (CTZ)] have shown low but significant levels of resistance after transfection into L. major wild-type parasites. In this work, we have shown the insert mapping and chromosomal identification of one of these loci (cosItz2). Functional analysis experiments associated with chromosomal localization by comparison at genomic database allowed us to identify two prospective gene-protein systems not related to the ergosterol biosynthesis and capable to confer wild-type cells resistance to ITZ-CTZ after transfection. We expected that this approach can open new insights for a better understanding of mechanisms of ITZ-CTZ action and resistance in Leishmania resulting in new strategies for the leishmaniasis treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322586     DOI: 10.1007/s00436-009-1418-9

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  35 in total

Review 1.  Advances in leishmaniasis.

Authors:  Henry W Murray; Jonathan D Berman; Clive R Davies; Nancy G Saravia
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

Review 2.  Gene amplification in Leishmania.

Authors:  S M Beverley
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

Review 3.  Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites.

Authors:  J A Urbina
Journal:  Parasitology       Date:  1997       Impact factor: 3.234

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 5.  Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years.

Authors:  J D Berman
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

Review 6.  Molecular mechanisms of drug resistance in fungi.

Authors:  H Vanden Bossche; P Marichal; F C Odds
Journal:  Trends Microbiol       Date:  1994-10       Impact factor: 17.079

Review 7.  Chemotherapy of leishmaniasis.

Authors:  Simon L Croft; Vanessa Yardley
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

8.  Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major.

Authors:  Adriano C Coelho; Stephen M Beverley; Paulo C Cotrim
Journal:  Mol Biochem Parasitol       Date:  2003-08-31       Impact factor: 1.759

9.  Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.

Authors:  A K Cruz; R Titus; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

10.  Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression.

Authors:  G M Kapler; C M Coburn; S M Beverley
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

View more
  1 in total

1.  Characterization of a Novel Endoplasmic Reticulum Protein Involved in Tubercidin Resistance in Leishmania major.

Authors:  Juliana Ide Aoki; Adriano Cappellazzo Coelho; Sandra Marcia Muxel; Ricardo Andrade Zampieri; Eduardo Milton Ramos Sanchez; Audun Helge Nerland; Lucile Maria Floeter-Winter; Paulo Cesar Cotrim
Journal:  PLoS Negl Trop Dis       Date:  2016-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.